Key facts
| Price (PPV) | 1,966 MAD |
|---|---|
| Dispensing status | Unscheduled — no prescription needed |
| Composition (DCI) | vaccin zona ( recombinantavec adjuvant ) |
| Class | Vaccines |
| ATC code | J07BK03 |
| Manufacturer | GLAXO SMITHKLINE |
| Presentation | Boite d'une dose |
| Hospital price | 1,715 MAD |
| Data collected on | 9/8/2026 |
Indications
Shingrix est indiqué dans la prévention du zona et des névralgies post-zostériennes (NPZ) chez : • les adultes de 50 ans ou plus; • les adultes de 18 ans ou plus, présentant un risque accru de zona. Shingrix doit être administré selon les recommandations officielles. Source : https://ec.europa.eu - 22 octobre 2025
Find an open pharmacy
On-call pharmacies near you
About Shingrix Une Dose(0
Shingrix Une Dose(0 belongs to the vaccines therapeutic class. In Morocco, this drug is marketed by GLAXO SMITHKLINE and is among the pharmaceutical specialties referenced by the Ministry of Health.
For any question about the use, effects, or drug interactions of Shingrix Une Dose(0, consult your doctor or pharmacist. This information is provided for educational purposes and does not replace medical advice.
Frequently Asked Questions about Shingrix Une Dose(0
Answers to common questions from Moroccan patients about this drug.